Published in Biochim Biophys Acta on October 08, 2013
A novel mathematical model of ATM/p53/NF- κB pathways points to the importance of the DDR switch-off mechanisms. BMC Syst Biol (2016) 1.41
PDL1 Regulation by p53 via miR-34. J Natl Cancer Inst (2015) 1.02
Differences in predictions of ODE models of tumor growth: a cautionary example. BMC Cancer (2016) 0.88
Inhibition of G9a induces DUSP4-dependent autophagic cell death in head and neck squamous cell carcinoma. Mol Cancer (2014) 0.83
The reversal of antineoplastic drug resistance in cancer cells by β-elemene. Chin J Cancer (2015) 0.80
The Antitumor Activity of the Novel Compound Jesridonin on Human Esophageal Carcinoma Cells. PLoS One (2015) 0.79
Regulation of p53 in NIH3T3 mouse fibroblasts following hyperosmotic stress. Physiol Rep (2015) 0.78
Dynamics of posttranslational modifications of p53. Comput Math Methods Med (2014) 0.78
Dynamic multiprotein assemblies shape the spatial structure of cell signaling. Prog Biophys Mol Biol (2014) 0.78
SC-III3, a novel scopoletin derivative, induces cytotoxicity in hepatocellular cancer cells through oxidative DNA damage and ataxia telangiectasia-mutated nuclear protein kinase activation. BMC Cancer (2014) 0.76
The Yin and Yang of DAXX regulation. Cell Cycle (2015) 0.75
Reaction-diffusion systems for spatio-temporal intracellular protein networks: A beginner's guide with two examples. Comput Struct Biotechnol J (2014) 0.75
A Novel Naphthalimide Compound Restores p53 Function in Non-small Cell Lung Cancer by Reorganizing the Bak·Bcl-xl Complex and Triggering Transcriptional Regulation. J Biol Chem (2015) 0.75
Circadian timing in cancer treatments. Annu Rev Pharmacol Toxicol (2010) 1.58
An age-and-cyclin-structured cell population model for healthy and tumoral tissues. J Math Biol (2007) 0.96
A combined experimental and mathematical approach for molecular-based optimization of irinotecan circadian delivery. PLoS Comput Biol (2011) 0.90
Implications of circadian clocks for the rhythmic delivery of cancer therapeutics. Philos Trans A Math Phys Eng Sci (2008) 0.87
Applying ecological and evolutionary theory to cancer: a long and winding road. Evol Appl (2012) 0.84
A spatial physiological model for p53 intracellular dynamics. J Theor Biol (2012) 0.82
Modeling the effects of space structure and combination therapies on phenotypic heterogeneity and drug resistance in solid tumors. Bull Math Biol (2014) 0.81
Modelling the genesis and treatment of cancer: the potential role of physiologically based pharmacodynamics. Eur J Cancer (2010) 0.81
Rhythms from seconds to days. Physiological importance and therapeutic implications. IEEE Eng Med Biol Mag (2008) 0.79
The dynamics of p53 in single cells: physiologically based ODE and reaction-diffusion PDE models. Phys Biol (2014) 0.78
A model of ischemia-induced neuroblast activation in the adult subventricular zone. PLoS One (2009) 0.77
Age-structured cell population model to study the influence of growth factors on cell cycle dynamics. Math Biosci Eng (2013) 0.77
A pressure model of immune response to mycobacterium tuberculosis infection in several space dimensions. Math Biosci Eng (2010) 0.77
Genotype- or Phenotype-Targeting Anticancer Therapies? Lessons from Tumor Evolutionary Biology. Curr Pharm Des (2016) 0.76
Gene therapy: the role of cytoskeleton in gene transfer studies based on biology and mathematics. Curr Gene Ther (2014) 0.75
Design and optimization of reaction chamber and detection system in dynamic labs-on-chip for proteins detection. IEEE Trans Biomed Eng (2013) 0.75